We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-17.80 | -6.46% | 257.80 | 257.20 | 257.60 | 268.40 | 255.80 | 267.80 | 25,210,555 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 40.47 | 5.28B |
Date | Subject | Author | Discuss |
---|---|---|---|
05/12/2016 17:00 | I`ve gone and bought a few today @ 233.5p UT tonight @ 238p Hope it`s settled down now......Fingers crossed ;-) | philanderer | |
05/12/2016 16:30 | Thanks for letting us know........but I still would like to see the price slide some more before I buy. | anley | |
05/12/2016 14:47 | Deutsche initiating coverage with 'buy' and 275p target edit: Proactiveinvestors.c After gaining elevation to the FTSE 100 in last week’s quarterly reshuffle, colostomy bag maker ConvaTec (LON:CTEC) got some more good news today as broker Deutsche Bank started coverage on the stock with a buy rating. The broker has set a 275p price target on the stock, which only floated on the main market in London at the end of October at an initial price of 225p. In lunchtime trading today, ConvaTec shares were 0.75p higher at 235.75p. Deutsche said the firm, which is a global medical products company focused on therapies for chronic conditions, enjoys leading positions across all of its franchises. In a note to clients, it said: “We expect sales and earnings growth to accelerate as the turnaround in OC (Ostomy Care) continues, other franchises appear in good shape, and margins expand due to its margin improvement program.” The broker concluded that ConvaTec shares look “good value.” | philanderer | |
02/12/2016 20:50 | Will most likely drift down to the offer price of 225p | gateside | |
02/12/2016 17:12 | and with a little movement in the shareholdings together with a weak market today has brought the price down............. | anley | |
02/12/2016 16:15 | Still like a bride`s nightie ;-) | philanderer | |
28/11/2016 12:28 | And the stabilisation by Goldmans should have ended last friday. edit: And into the FTSE100 this week. | philanderer | |
28/11/2016 10:58 | There is a build up on the trading of the shares but not good enough just yet to go in and buy. In an ideal world I would like this to slip to the 225p issue price. | anley | |
24/11/2016 14:12 | Yes , good call anley. Still doesn`t feel the right time to buy just yet. | philanderer | |
24/11/2016 09:54 | Me too but the more I look at ConvaTec the more I see a fit with Smith & N or a bid from the USA...............in about a years time. | anley | |
16/11/2016 13:05 | Still sitting on my hands here ;-) | philanderer | |
02/11/2016 17:38 | Agree anley , let the dust settle on this one for a while. | philanderer | |
02/11/2016 17:23 | Some good price movements since dealings started so I will watch for a few days before I invest. | anley | |
31/10/2016 22:54 | Pharma firm ConvaTec climbed on its first day of trading. The medical products company listed on the stock exchange in the largest European healthcare float for more than 20 years. Shares finished their first day up 4.1 per cent, or 10p, at 250p | philanderer | |
31/10/2016 22:52 | ConvaTec is a global medical products and technologies company, offering products and services in the areas of wound and skin care; ostomy care; continence and critical care; and infusion devices ConvaTec Ltd Intention to Float RNS Number : 4500L ConvaTec Ltd 03 October 2016 With shares placed at 225p, ConvaTec raised £1.46bn, valuing the business at £4.4bn. London Stock Exchange said it was among the top-ten largest healthcare IPOs of all time. Private equity owners Nordic capital and Avista Capital Partners have used the listing to offload part of their stakes in the business, although they will retain a 45.1% and 19.5% stake in the firm, respectively. The company has said that most of the cash windfall will be used to pay down some of its debt. Its net debt sits at just above £3.3bn, or more than seven times its adjusted cash profits, while it hopes the IPO will see that fall to 3.5times, or £1.66bn. | philanderer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions